Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 1/20 | 0.43 |
| ▸ | MMP1 | P03956 | 3/20 | 0.39 |
| ▸ | MMP7 | P09237 | 3/20 | 0.39 |
| ▸ | MMP12 | P39900 | 3/20 | 0.39 |
| ▸ | MMP13 | P45452 | 3/20 | 0.39 |
| ▸ | ACE | P12821 | 2/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 6/20 | 0.37 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | NR1H3 | Q13133 | 5/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | DRD1 | P21728 | 1/20 | 0.34 |
| ▸ | DRD4 | P21917 | 1/20 | 0.34 |
| ▸ | DRD5 | P21918 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6098066 | 0.93 | HTR7 (0.42) | HTR7NR1H2NR1H3KMT2ADRD2 | |
| SCHEMBL6097626 | 0.87 | HTR7 (0.40) | HTR7NR1H2NR1H3KMT2A | |
| SCHEMBL6096984 | 0.83 | HTR7 (0.42) | HTR7NR1H2NR1H3KMT2A | |
| SCHEMBL6098365 | 0.82 | HTR7 (0.40) | HTR7NR1H2NR1H3KMT2A | |
| SCHEMBL6097231 | 0.82 | HTR7 (0.38) | HTR7NR1H2NR1H3KMT2A | |
| Hydrochloric Acid SCHEMBL6096973 | 0.81 | HTR7 (0.39) | HTR7NR1H2NR1H3KMT2A | |
| SCHEMBL6096562 | 0.81 | HTR7 (0.38) | HTR7NR1H2NR1H3KMT2A | |
| SCHEMBL6097772 | 0.74 | HTR7 (0.50) | HTR7NR1H2KMT2ADRD2DRD1 | |
| Hydrochloric Acid SCHEMBL6094819 | 0.72 | MMP1 (0.40) | HTR7MMP1MMP7MMP12MMP13 | |
| SCHEMBL6097225 | 0.71 | HTR7 (0.52) | HTR7NR1H2DRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7101892-B2 | Sulfone derivatives as 5-HT7 receptor ligands | MERCK SHARP & DOHME LTD. | 2006-09-05 | — | — | US | disclosed |
| US-20040229864-A1 | Sulfone derivatives as 5-HT7 receptor ligands | MERCK SHARP & DOHME LTD. (GB) | 2004-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040229864-A1 | Sulfone derivatives as 5-HT7 receptor ligands | HTR7, HTR2C, HTR1A | HTR7 1/4885MMP1 4603/4885MMP7 2868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.